Compare Bank Capital Indonesia Tbk (BACA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Bank Capital Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank Capital Indonesia Tbk trades at Rp101 (market cap 2.03T, 1.66M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: Bank Capital Indonesia Tbk is far larger — about 3.5× UBC Medical Indonesia Tbk.'s market cap, and Bank Capital Indonesia Tbk is more actively traded (1.66M versus 1.44M). Which is the better fit depends on your goals.
| BACA | LABS | |
|---|---|---|
Market Cap | 2.03T | 584.6B |
Volume | 1.66M | 1.44M |
Lot | 16.61K | 14.4K |
Turnover | 166.37M | 209.72M |
Average Price | 100.17 | 145.64 |
Value | 166.37M | 209.72M |
Indicative Equilibrium Price | 101 | 146 |
Indicative Equilibrium Volume | 20 | 753 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Capital Indonesia Tbk
PT Bank Capital Indonesia (the company) was established under its original name of PT Bank Credit Lyonnais base on notarial deed No.139 of Mrs Siti Pertiwi, S.H, dated on Apr 20, 1989. The Company's articles of association has been amended several times, most recently by notarial deed No. 60 of Eliwati Tjitra, S.H., dated Jul 17, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering.
Read more on BACA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
